Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1401-1420 of 3,348 trials

COMPLETEDNA2.2 miles

Rewards Sensitivity After Brain Injury

NCT06510023

A study measuring rewards sensitivity in individuals with acquired brain injury at an acute rehabilitation level.

Acquired Brain Injury

Shirley Ryan AbilityLab31 participantsStarted Mar 2021

Chicago, Illinois, United States

COMPLETEDPhase 1/22.2 miles

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

NCT03320330

This phase I/II trial studies the side effects and best dose of pepinemab and to see how well it works in treating younger patients with solid tumors that have come back after treatment, or do not respond to treatment. Immunotherapy with monoclonal antibodies, such as pepinemab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

Recurrent Malignant Solid NeoplasmRecurrent OsteosarcomaRefractory Malignant Solid Neoplasm+1 more

Children's Oncology Group26 participantsStarted Jan 2018

Birmingham, Alabama, United States • Los Angeles, California, United States • Orange, California, United States +21 more locations

Rewards Sensitivity After Brain Injury

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Rheumatoid Arthritis Trials in Other Cities

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Individual Differences in Drug Response

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Impact of Microvascular Inflammation on Kidney Allograft Outcome

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing

QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

Phase I/II Study of Avelumab in Pediatric Cancer Participants

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Other Conditions in Chicago